This specific ISBN edition is currently not available.View all copies of this ISBN edition:
Destined to become every regulatory director's essential desktop companion
rofessionals working to submit major documents to the Food and Drug Administration (FDA) are guaranteed to encounter numerous unexpected and daunting hurdles. Guidebook for Drug Regulatory Submissions offers a readable and clearly written road map for effective submission of documents for required regulatory reviews during drug development.
Demystifying this complex, high-stakes process, author and nationally recognized drug regulation expert Sandy Weinberg presents professionals with authoritative tips, tools, and advice including suggestions for preparation, checklists for submission, an FDA evaluation tool for review, and copies of relevant FDA guidelines.
As well, vital information is provided on the most common types of submissions, including:
Orphan Drug Applications
Investigatory New Drug Applications (INDAs)
New Drug Applications (NDAs)
Abbreviated New Drug Applications (ANDAs)
This reference also explores the pressures affecting the industry and the general public, as well as how these pressures will change the general nature and specific aspects of the submissions process over the near future. In addition, retired Canadian trade consul and regulatory consultant Carl Rockburne guest-authors a chapter comparing the FDA process to the four other major regulatory environments of Canada, the European Union, Japan, and Australia.
Guidebook for Drug Regulatory Submissions is more than a useful guide it is an essential tool to be kept on the desk of every regulatory director, submissions manager, vice president of Regulatory Affairs, and Food and Drug Administration reviewer responsible for the process of drug regulatory submissions.
"synopsis" may belong to another edition of this title.
SANDY WEINBERG is the former Vice President for Regulatory Affairs and Quality Assurance at Tikvah Therapeutics, Inc., and is now Associate Professor of Health Care Management and Director of the Master in Health Administration Graduate Program at Clayton State University in Atlanta. He has thirty years of experience in the field of drug regulatory affairs and is the author of twelve books, most recently Good Laboratory Practice Regulations, Fourth Edition.Review:
“The Guidebook for Drug Regulatory Submissions offers a readable and clearly written road map for effective submission of documents for required regulatory reviews during drug development.” (Pharmaceutical Outsourcing, April 2009)
"About this title" may belong to another edition of this title.
Book Description John Wiley & Sons Inc, 2009. Hardcover. Condition: Brand New. 1st edition. 392 pages. 9.75x6.50x0.75 inches. In Stock. Seller Inventory # zk0470371382
Book Description Wiley, 2009. Hardcover. Condition: New. book. Seller Inventory # M0470371382
Book Description Wiley, 2009. Hardcover. Condition: New. Never used!. Seller Inventory # P110470371382
Book Description Wiley, 2009. Hardcover. Condition: New. Brand New!. Seller Inventory # VIB0470371382
Book Description Wiley, 2009. Hardcover. Condition: New. 1. Seller Inventory # DADAX0470371382
Book Description Wiley. Hardcover. Condition: New. 0470371382 New Condition. Seller Inventory # NEW7.0177259